Reduced Protein C Levels – a Contributory Factor for Stroke in Sickle Cell Disease

Thromb Haemost 1998; 79(04): 879-880
DOI: 10.1055/s-0037-1615083

Letters to the Editor

Schattauer GmbH

U. Khanduri

¹Dept. of Haematology and Child Health, College of Medicine, Sultan Qaboos University, Muscat, Sultanate of Oman

,

D. Gravell

¹Dept. of Haematology and Child Health, College of Medicine, Sultan Qaboos University, Muscat, Sultanate of Oman

,

B. S. Christie

¹Dept. of Haematology and Child Health, College of Medicine, Sultan Qaboos University, Muscat, Sultanate of Oman

,

Zakia Al Lamki

¹Dept. of Haematology and Child Health, College of Medicine, Sultan Qaboos University, Muscat, Sultanate of Oman

,

M. Zachariah

¹Dept. of Haematology and Child Health, College of Medicine, Sultan Qaboos University, Muscat, Sultanate of Oman

,

E. Cherian

¹Dept. of Haematology and Child Health, College of Medicine, Sultan Qaboos University, Muscat, Sultanate of Oman

References
1 Ohene-Frempong K. Stroke in sickle cell disease: demographic, clinical and therapeutic considerations. Semin Hematol 1991; 28: 213-9.
2 El Hazmi MAF, Warsy AS, Bahakim H. Blood protein C and S in sickle cell disease. Acta Hematol 1993; 90: 114-9.
3 Peters M, Plaat BEC, ten Cate H, Wolters HJ, Weening RS, Brandjes DPM. Enhanced thrombin generation in children with sickle cell disease. Thromb Haemost 1994; 71: 169-72.
4 Balkaran B, Char G, Morris JS, Thomas PW, Serjeant BE, Serjeant GR. Stroke in cohort of patients with homozygous sickle cell disease. J Pediatr 1992; 120: 360-6.
5 Abboud MR, Jackson SM, Barredo J, Holden KR, Cure J, Laver J. Neurological complications following bone marrow transplantation for sickle cell disease. Bone Marrow Transplant 1996; 17: 405-7.
6 Walters MC, Sullivan KM, Bernaudin F, Souillet G, Vannier JP, Johnson FL, Lenarsky C, Powars D, Bunin N, Ohene-Frempong K, Wall D, Michel G, Plouvier E, Bodigoni P, Lutz P, Sanders JE, Mathews DC, Patience M, Appelbaum FR, Storb R. Neurological complications after allogeneic marrow transplantation for sickle cell anaemia. Blood 1995; 85 (Suppl. 04) 879-84.
7 Wolters HJ, ten Cate H, Thomas LLM, Brandjes DPM, van der Ende A, van der Heidon Y, van Eps LWS. Low intensity oral anticoagulation in sickle cell diesease reverses the prethrombotic state: promises for treatment?. Br J Haematol 1995; 90: 715-7.